4//SEC Filing
Sylvain Jereme M 4
Accession 0001093557-25-000079
CIK 0001093557other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:25 PM ET
Size
5.4 KB
Accession
0001093557-25-000079
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Sylvain Jereme M
EVP, Chief Financal Officer
Transactions
- Sale
Common Stock
2025-03-12$70.38/sh−12,001$844,632→ 123,481 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Included in this number are 83,328 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001681267
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:25 PM ET
- Size
- 5.4 KB